Cristina Verzeroli1*, Laura Russo1*, Sara Gamba1*, Carmen J Tartari, PhD1*, Silvia Bolognini1*, Chiara Ticozzi1*, Patricia Gomez-Rosas, MD1,2,3*, Francesca Schieppati, MD1,4*, Roberta Sarmiento, MD5*, Giovanna Masci, MD6*, Carlo Tondini, MD7*, Fausto Petrelli, MD8*, Francesco Giuliani, MD9*, Andrea D'Alessio, MD10*, Filippo De Braud, MD11*, Armando Santoro, MD12*, Giampietro Gasparini, MD5*, Roberto Labianca, MD13*, Luca Barcella, MD1*, Marina Marchetti, PhD1,14* and Anna Falanga, MD4
1Department of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy
2Maastricht University Medical Center (MUMC+), Cardiovascular Research Institute Maastricht (CARIM), Maastricht, Netherlands
3Hospital de Oncologia, Unidad Medica de Alta Especialidad (UMAE), Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico
4School of Medicine, University of Milano Bicocca, Milan, Italy
5Oncology Unit, San Filippo Neri Hospital, Rome, Italy
6Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Italy
7Oncology Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy
8Oncology Unit, Treviglio-Caravaggio Hospital, Treviglio, Italy
9Oncology Unit, IRCCS Cancer Institute Giovanni Paolo II, Bari, Italy
10Medical Oncology and Internal Medicine, Policlinico San Marco, Bergamo, Italy
11Oncology Unit, IRCCS National Cancer Institute, Milan, Italy
12IRCCS Humanitas Research Hospital, Rozzano, Italy
13Fondazione ARTET Onlus, Bergamo, Italy
14School of Medicine and Surgery, University, Milan, Italy